MAP1LC3A and fatty liver disease: A recent study revealed that autophagy activation following treatment with a polyphenol fraction could prevent nonalcoholic hepatic steatosis by upregulation of autophagy markers, such as beclin-1, and LC3 conversion with decreased p62 levels in the liver tissue of rats fed a cafeteria diet [25].